Two of the leaders at iPierian, the high-profile stem cell startup in South San Francisco co-founded by scientists at the Harvard Stem Cell Institute, have left the company in the wake of its strategic shift this spring, Xconomy has learned. Corey Goodman, the prominent neuroscientist and biotech executive, has resigned his position as chairman of the board at iPierian, according to sources familiar with the situation.